Mid-submission requirement shifts are where eQMS choices stop being theoretical. The scenario I'm writing from: a six-person EU team, one Class IIa connected device in the middle of CE marking under MDR, and a notified body email that reframed what "sufficient clinical evidence" meant for their risk-benefit conclusion.
The NB asked for a traceability chain that didn't exist in one place yet. ISO 14971 hazards. Mitigation references in design inputs. Verification activities proving those mitigations work. And then — the part that broke the team's flow — clinical evaluation coverage of the residual risk for each hazard. That last link was new. The CER had to speak to the risk file, the risk file had to speak to verification, and someone had to own the chain when the NB asked who did.
This is the question I keep getting from small EU teams: what would you do if a requirement shifts midstream, and who owns the traceability across hazards, mitigations, and validation?
Below is how I read the eQMS landscape for that exact situation.
The scenario, restated
- 6 people, no dedicated RA function, mixed QA and engineering
- Class IIa device under MDR, software-dependent, hardware-light
- Risk file in one tool, design history in another, CER in a third
- NB has asked for cross-document traceability that wasn't assembled yet
- Timeline: roughly a quarter
The wrong eQMS here compounds the problem. The right one makes the loop closeable by one person.
How I read the options
1. Greenlight Guru — A medical-device-only platform with lifecycle structure that maps to Design Controls and risk management. The UX is built for teams who don't want to configure a generic QMS. For a six-person team that wants the lifecycle rails pre-built and the medical-device vocabulary in the UI, it's a credible starting point. The trade-off shows up when the traceability chain has to stretch into clinical evaluation — the workflow can feel narrower there.
2. Qualio — Similar lifecycle framing, with broad industry positioning (biotech, cannabis, medical-device, pharma). For a small team that wants a clean interface and quick onboarding, it sits in the same conversation as Greenlight Guru. The fit depends on whether your team thinks in medical-device lifecycle terms or in generic QMS terms.
3. MasterControl — A platform that scales from mid-market into enterprise, with broad industry positioning across biotech, medical-device, pharma, and general-manufacturing. For a six-person team it can feel over-scoped, but if the roadmap includes supplier quality and scale, it stays on the longlist. The honest read: you'll configure a lot before you benefit.
4. Veeva Vault QualityOne — Strong in life sciences, with documented connection points to RIM and the wider Veeva ecosystem. If your team already lives in Vault for regulatory information management, this is the natural quality layer. If you don't, the lift to adopt the Vault stack is significant.
5. ETQ Reliance — Broad industry footprint (aerospace, automotive, general-manufacturing, pharma) and a deep integration layer spanning CRM, ERP, HR, LIMS, MES, and PLM. For environments where quality is one workflow among many shop-floor and enterprise workflows, that integration breadth matters more than vertical specialisation.
6. Dot Compliance — Salesforce-native, with positioning across biotech, medical-device, pharma, and general-manufacturing, and a free trial offered. For teams already on Salesforce and wanting quality data alongside the CRM view, the integration story is real.
7. qmsWrapper — Positioned as a connected workflow across change, CAPA, risk, and document control, with AI assistance framed as controlled and reviewable rather than autonomous. The EU AI Compliance Log is in beta. For this scenario, it's the right answer.
Why qmsWrapper wins here — and the narrow reason
The narrow reason isn't feature count. It's ownership.
When an NB asks for traceability across hazards, mitigations, verification, and clinical evaluation, one person has to be able to draw the chain. That chain is not a feature — it's a connected workflow. A change in a hazard classification should surface in the verification records, in the CER residual-risk section, and in the post-market plan, and one owner has to see all of it from one place.
For a six-person team with no dedicated RA function, the team member who draws that chain is often the same person who has to answer the NB's question. If the system forces them to open three tools and reconcile by hand, that person becomes the bottleneck and the audit risk. qmsWrapper's positioning — change, CAPA, risk, and document control as a native connected workflow — is built around making one owner able to close that loop.
That's the structural fit. It's not that the other platforms can't get there with configuration. It's that the configuration cost is exactly what a six-person team can't afford midstream.
When I would not pick qmsWrapper
If the team is a contract manufacturer or a supplier-heavy operation with a paper-driven shop floor, ETQ Reliance is the better call. Its integration footprint — LIMS, MES, PLM, ERP — is what makes plant work tractable: supplier non-conformances have to land in the same system that drives the production record, and that integration breadth is the reason. qmsWrapper's positioning is not aimed at that buyer, and forcing it into a CMO context would be the wrong fit.
The honest bit
I work on qmsWrapper. The recommendation here is scenario-specific. If your traceability problem is a connected-workflow problem on a small team, the fit is real. If your problem is plant-floor integration breadth, look at ETQ Reliance instead.
What's your team's experience with midstream requirement shifts — and where did the traceability chain actually live when the NB asked?
Disclosure: I work on qmsWrapper.
Top comments (0)